Literature DB >> 2202449

Leukaemia and cancer chemotherapy.

C J Williams1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2202449      PMCID： PMC1663448          DOI： 10.1136/bmj.301.6743.73

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer.

Authors:  S K Chambers; R L Chopyk; J T Chambers; P E Schwartz; T P Duffy
Journal:  Cancer       Date:  1989-12-15       Impact factor: 6.860

2.  Hematologic neoplasia in patients treated for Hodgkin's disease.

Authors:  C N Coleman; C J Williams; A Flint; E J Glatstein; S A Rosenberg; H S Kaplan
Journal:  N Engl J Med       Date:  1977-12-08       Impact factor: 91.245

3.  Risk of second cancers after treatment for Hodgkin's disease.

Authors:  M A Tucker; C N Coleman; R S Cox; A Varghese; S A Rosenberg
Journal:  N Engl J Med       Date:  1988-01-14       Impact factor: 91.245

4.  Leukemia following Hodgkin's disease.

Authors:  J M Kaldor; N E Day; E A Clarke; F E Van Leeuwen; M Henry-Amar; M V Fiorentino; J Bell; D Pedersen; P Band; D Assouline
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

5.  Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.

Authors:  P Valagussa; A Santoro; F Fossati Bellani; F Franchi; A Banfi; G Bonadonna
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

6.  Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.

Authors:  J Pedersen-Bjergaard; S O Larsen
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

7.  Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.

Authors:  A S Glicksman; T F Pajak; A Gottlieb; N Nissen; L Stutzman; M R Cooper
Journal:  Cancer Treat Rep       Date:  1982-04

8.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

Authors:  M M Le Beau; K S Albain; R A Larson; J W Vardiman; E M Davis; R R Blough; H M Golomb; J D Rowley
Journal:  J Clin Oncol       Date:  1986-03       Impact factor: 44.544

9.  The prognostic value of chromosome studies in patients with the preleukemic syndrome (hemopoietic dysplasia).

Authors:  R L Anderson; G C Bagby
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

10.  Therapy-related preleukemic syndrome.

Authors:  R L Anderson; G C Bagby; K Richert-Boe; R E Magenis; R D Koler
Journal:  Cancer       Date:  1981-04-01       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.